AdvanSource Biomaterials Corp company info

CIK 1011060
IRS Number 043186647
State of incorporation DE
Business address 229 ANDOVER STREET
Mail address 229 ANDOVER STREET

Short summary

AdvanSource Biomaterials Corp is a Massachusetts company, with head office located at 229 Andover Street Wilmington, Massachusetts 01887. In 2018 the company owned a total of 2.92 million USD worth of assets, including 1.02 million USD worth of current assets. 2011 was the year when the company amassed the most assets.

AdvanSource Biomaterials Corp Income Statement

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Gross Profit 0.140.971.381.621.652.101.432.12
Selling, General and Administrative Expense 2.491.841.611.431.391.391.241.56
Research and development 0.730.610.440.390.310.310.330.38
Operating Expenses 3.332.472.051.831.581.701.571.94
Interest expense 0.170.340.360.390.370.370.38
Net income -3.19-1.81-1.01-0.52-0.320.03-0.51-0.20

AdvanSource Biomaterials Corp Balance Sheet

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Cash and cash equivalents 2.430.160.86
Inventories 0.420.350.260.150.330.180.190.340.24
Property, Plant and Equipment, Gross 0.00
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.00-0.00-0.00-0.00-0.00-0.00-0.000.00
Total assets 3.473.612.982.682.862.652.792.822.92
Current assets 0.821.070.590.470.770.630.820.881.02
Total current liabilities 0.660.360.520.550.560.561.311.251.18
Other Accrued Liabilities, Noncurrent
Total liabilities 0.442.392.612.672.692.713.473.413.34
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -35.12-36.76-37.64-38.03-37.88-38.15-38.78-38.99-38.83

AdvanSource Biomaterials Corp Cash Flow

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Net income -3.19-1.81-1.01-0.52-0.320.03-0.51-0.20
Depreciation and amortization
Accounts receivable 0.05-
Accounts payable 0.01-
Deferred revenue -0.02-0.01-0.010.08-0.06-0.03
Net Cash Provided by (Used in) Operating Activities -2.59-1.75-0.480.17-0.190.06-0.200.11
Net Cash Provided by (Used in) Investing Activities -0.00-0.010.01-0.01
Proceeds from Issuance of Common Stock 0.020.01
Net Cash Provided by (Used in) Financing Activities 0.021.760.11-0.01-0.01-0.060.15-0.01